NASDAQ:LHCG - LHC Group Stock Price, Forecast & News

LHC Group's stock was trading at $127.00 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, LHCG shares have decreased by 2.0% and is now trading at $124.41. View which stocks have been mosted impacted by Coronavirus.

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for LHC Group in the last year. There are currently 2 hold ratings and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for LHC Group.

LHC Group is scheduled to release its next quarterly earnings announcement on Wednesday, May 13th 2020. View our earnings forecast for LHC Group.

LHC Group, Inc. (NASDAQ:LHCG) posted its quarterly earnings results on Wednesday, February, 26th. The health services provider reported $1.15 EPS for the quarter, hitting the Thomson Reuters' consensus estimate of $1.15. The health services provider earned $531.32 million during the quarter, compared to analyst estimates of $541.57 million. LHC Group had a net margin of 4.60% and a return on equity of 9.52%. View LHC Group's earnings history.

LHC Group issued an update on its FY20 earnings guidance on Wednesday, February, 26th. The company provided earnings per share guidance of $4.60-4.80 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.74. The company issued revenue guidance of $2.13-2.18 billion, compared to the consensus revenue estimate of $2.24 billion.

11 equities research analysts have issued 12-month price targets for LHC Group's shares. Their forecasts range from $120.00 to $180.00. On average, they expect LHC Group's stock price to reach $147.70 in the next year. This suggests a possible upside of 18.7% from the stock's current price. View analysts' price targets for LHC Group.

News headlines about LHCG stock have been trending somewhat positive on Sunday, InfoTrie Sentiment reports. The research firm ranks the sentiment of news coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. LHC Group earned a daily sentiment score of 1.2 on InfoTrie's scale. They also assigned media headlines about the health services provider a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View the latest news aboutLHC Group.

LHC Group saw a decline in short interest in the month of March. As of March 13th, there was short interest totaling 1,364,500 shares, a decline of 9.6% from the February 27th total of 1,510,000 shares. Based on an average daily volume of 368,700 shares, the days-to-cover ratio is presently 3.7 days. Currently, 4.6% of the company's stock are sold short. View LHC Group's Current Options Chain.

Some companies that are related to LHC Group include Laboratory Corp. of America (LH), Quest Diagnostics (DGX), Davita (DVA), Chemed (CHE), Amedisys (AMED), AMN Healthcare Services (AMN), R1 RCM (RCM), MEDNAX (MD), CorVel (CRVL), The Providence Service (PRSC), Tivity Health (TVTY), Cross Country Healthcare (CCRN) and Interpace Diagnostics Group (IDXG).

Based on aggregate information from My MarketBeat watchlists, some companies that other LHC Group investors own include Verizon Communications (VZ), Home Depot (HD), Cisco Systems (CSCO), Alibaba Group (BABA), CVS Health (CVS), Visa (V), Chevron (CVX), Walt Disney (DIS), AT&T (T) and Intel (INTC).

LHC Group trades on the NASDAQ under the ticker symbol "LHCG."

LHC Group's stock is owned by a variety of institutional and retail investors. Top institutional investors include FMR LLC (5.29%), State Street Corp (2.77%), Alliancebernstein L.P. (2.13%), Victory Capital Management Inc. (2.12%), Victory Capital Management Inc. (2.10%) and Bank of New York Mellon Corp (1.91%). Company insiders that own LHC Group stock include Donald Dwayne Stelly, Jeff Reibel, John L Indest, Joshua L Proffitt, Keith G Myers, Ronald T Nixon and Tyree G Wilburn. View institutional ownership trends for LHC Group.

LHCG stock was sold by a variety of institutional investors in the last quarter, including Redwood Investments LLC, Rothschild & Co. Asset Management US Inc., Man Group plc, Robeco Institutional Asset Management B.V., Nuveen Asset Management LLC, Principal Financial Group Inc., Sei Investments Co., and Arizona State Retirement System. Company insiders that have sold LHC Group company stock in the last year include Donald Dwayne Stelly, John L Indest, Keith G Myers, and Ronald T Nixon. View insider buying and selling activity for LHC Group.

LHCG stock was acquired by a variety of institutional investors in the last quarter, including FMR LLC, Norges Bank, Magnetar Financial LLC, Sumitomo Mitsui Trust Holdings Inc., Janus Henderson Group PLC, Westwood Management Corp IL, Columbus Circle Investors, and Bank of New York Mellon Corp. View insider buying and selling activity for LHC Group.

Shares of LHCG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of LHCG stock can currently be purchased for approximately $124.41.

LHC Group has a market capitalization of $3.92 billion and generates $2.08 billion in revenue each year. The health services provider earns $95.73 million in net income (profit) each year or $4.47 on an earnings per share basis. LHC Group employs 30,399 workers across the globe. View additional information about LHC Group.

The official website for LHC Group is http://www.lhcgroup.com/.

LHC Group's mailing address is 901 HUGH WALLIS ROAD SOUTH, LAFAYETTE LA, 70508. The health services provider can be reached via phone at 337-233-1307 or via email at [email protected]